DFTX vs. CMPS
DFTX (Definium Therapeutics, Inc) and CMPS (COMPASS Pathways plc) are both stocks. Both are in the Healthcare sector — DFTX in Biotechnology, CMPS in Medical Care Facilities. Over the past 3 years, DFTX returned 123.15%/yr vs 17.13%/yr for CMPS. At a 0.43 correlation, their price movements are largely independent.
Performance
DFTX vs. CMPS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DFTX achieves a 173.86% return, which is significantly higher than CMPS's 83.04% return.
DFTX
- 1D
- 49.80%
- 1M
- 62.98%
- YTD
- 173.86%
- 6M
- 175.71%
- 1Y
- 420.14%
- 3Y*
- 123.15%
- 5Y*
- —
- 10Y*
- —
CMPS
- 1D
- 0.80%
- 1M
- 6.94%
- YTD
- 83.04%
- 6M
- 93.42%
- 1Y
- 172.79%
- 3Y*
- 17.13%
- 5Y*
- -17.69%
- 10Y*
- —
DFTX vs. CMPS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
DFTX Definium Therapeutics, Inc | 173.86% | 92.39% | 90.16% | 66.36% | -78.74% |
CMPS COMPASS Pathways plc | 83.04% | 82.54% | -56.80% | 8.97% | -41.00% |
Correlation
The correlation between DFTX and CMPS is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.48 |
Correlation (All Time) Calculated using the full available price history since Jul 11, 2022 | 0.43 |
The correlation between DFTX and CMPS has been stable across timeframes, ranging from 0.43 to 0.51 - a consistent structural relationship.
Fundamentals
DFTX:
$3.99B
CMPS:
$1.65B
DFTX:
-$2.57
CMPS:
-$1.73
DFTX:
14.31
CMPS:
5.04
DFTX:
$0.00
CMPS:
$0.00
DFTX:
$0.00
CMPS:
$0.00
DFTX:
-$206.36M
CMPS:
-$312.16M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DFTX vs. CMPS — Risk / Return Rank
DFTX
CMPS
DFTX vs. CMPS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Definium Therapeutics, Inc (DFTX) and COMPASS Pathways plc (CMPS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DFTX | CMPS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.70 | ||
| Sortino ratioReturn per unit of downside risk | +3.03 | ||
| Omega ratioGain probability vs. loss probability | 1.64 | 1.36 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 17.09 | 4.55 | +12.54 |
| Martin ratioReturn relative to average drawdown | 53.86 | 12.02 | +41.84 |
Loading charts...
Drawdowns
DFTX vs. CMPS - Drawdown Comparison
The maximum DFTX drawdown since its inception was -86.01%, smaller than the maximum CMPS drawdown of -96.03%. Use the drawdown chart below to compare losses from any high point for DFTX and CMPS.
Loading charts...
Drawdown Indicators
| DFTX | CMPS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.01% | -96.03% | +10.02% |
Max Drawdown (1Y)Largest decline over 1 year | -24.79% | -38.22% | +13.43% |
Max Drawdown (3Y)Largest decline over 3 years | -58.38% | -81.00% | +22.62% |
Max Drawdown (5Y)Largest decline over 5 years | — | -95.20% | — |
Current DrawdownCurrent decline from peak | 0.00% | -78.67% | +78.67% |
Average DrawdownAverage peak-to-trough decline | -50.97% | -74.12% | +23.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.86% | 16.74% | -8.88% |
Volatility
DFTX vs. CMPS - Volatility Comparison
Definium Therapeutics, Inc (DFTX) has a higher volatility of 42.10% compared to COMPASS Pathways plc (CMPS) at 22.02%. This indicates that DFTX's price experiences larger fluctuations and is considered to be riskier than CMPS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DFTX | CMPS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 42.10% | 22.02% | +20.08% |
Volatility (6M)Calculated over the trailing 6-month period | 55.59% | 67.98% | -12.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.81% | 103.39% | -24.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.41% | 80.05% | +7.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 87.41% | 82.24% | +5.17% |
Dividends
DFTX vs. CMPS - Dividend Comparison
Neither DFTX nor CMPS has paid dividends to shareholders.
Financials
DFTX vs. CMPS - Financials Comparison
This section allows you to compare key financial metrics between Definium Therapeutics, Inc and COMPASS Pathways plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
DFTX and CMPS have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DFTX has higher volatility (42.10%) compared to CMPS (22.02%). In terms of maximum drawdown, DFTX dropped -86.01% vs CMPS's -96.03%.
DFTX currently has the higher Sharpe Ratio (5.39 vs 1.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DFTX and CMPS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer